Jabak Discussed With The Syndicate Of Hospitals Owners The Health Sector Issues And Received An Invi

التصنيف العلاجي	الاسم	أساسي / جنيسي	التركيبة العلمية	العيار	الشكل الصيدلاني	سعر المبيع من العموم
L04AB06	SIMPONI	BioTech	Golimumab - 100mg/1ml	100mg/1ml	Injectable solution	72,719,241 L.L
L04AC05	STELARA	BioTech	Ustekinumab - 45mg	45mg	Injectable solution	151,777,679 L.L
L04AC05	STELARA	BioTech	Ustekinumab - 90mg	90mg	Injectable solution	151,777,679 L.L
M03AC11	SISACURE	G	Cisatracurium (besylate) - 20mg/10ml	20mg/10ml	Injectable solution	1,408,347 L.L
B05XA02	SODIUM BICARBONATE	G	Sodium bicarbonate - 4.2g/100ml	4.2g/100ml	Injectable solution	742,370 L.L
B05XA02	SODIUM BICARBONATE	G	Sodium bicarbonate - 8.4g/100ml	8.4%	Injectable solution	959,565 L.L
L04AC18	SKYRIZI	BioTech	Risankizumab - 75mg	75mg	Injectable solution	194,911,251 L.L
B05XA02	SODIUM BICARBONATE	G	Sodium bicarbonate - 1.4g/100ml	1.4g/100ml	Injectable solution	258,887 L.L
L04AC18	SKYRIZI	BioTech	Risankizumab - 150mg	150mg	Injectable solution	194,911,251 L.L
H01CB02	SANDOSTATIN	B	Octreotide - 0.1mg/ml	0.1mg/ml	Injectable solution	1,038,790 L.L
J02AC01	STABILANOL	G	Fluconazole - 2mg/ml	2mg/ml	Injectable solution	1,242,583 L.L
H01CB03	SOMATULINE AUTOGEL	B	Lanreotide (acetate) - 90mg	90mg	Injectable solution	48,383,450 L.L
H01CB03	SOMATULINE AUTOGEL	B	Lanreotide (acetate) - 120mg	120mg	Injectable solution	57,492,826 L.L
H01CB05	SIGNIFOR	B	Pasireotide (diaspartate) - 0.3mg/ml	0.3mg/ml	Injectable solution	168,719,438 L.L
H01CB05	SIGNIFOR	B	Pasireotide (diaspartate) - 0.6mg/ml	0.6mg/ml	Injectable solution	180,355,261 L.L
H01CB05	SIGNIFOR	B	Pasireotide (diaspartate) - 0.9mg/ml	0.9mg/ml	Injectable solution	183,846,008 L.L
B05XA03	SERUFLEX SODIUM CHLORIDE 0.9% INJECTION USP	G	Sodium chloride - 0.9%	0.9%	Injectable solution	156,288 L.L
B05XA03	SERUFLEX SODIUM CHLORIDE 0.9% INJECTION USP	G	Sodium chloride - 0.9%	0.9%	Injectable solution	165,482 L.L
B05XA03	SERUFLEX SODIUM CHLORIDE 0.9% INJECTION, USP	G	Sodium chloride - 0.9%	0.9%	Injectable solution	176,974 L.L
B05XA03	SERUFLEX SODIUM CHLORIDE 0.9% INJECTION, USP	G	Sodium chloride - 0.9%	0.9%	Injectable solution	163,184 L.L
B05XA03	SERUFLEX SODIUM CHLORIDE 0.9% INJECTION, USP	G	Sodium chloride - 0.9%	0.9%	Injectable solution	156,288 L.L
A10AE54	SULIQUA	BioTech	Insulin glargine - 100IU/ml, Lixisenatide - 50mcg/ml		Injectable solution	11,286,573 L.L
B05XA03	SODIUM CHLORIDE	G	Sodium chloride - 0.9%	0.9%	Injectable solution	4,143,943 L.L
A10AE54	SULIQUA	BioTech	Insulin glargine - 100IU/ml, Lixisenatide - 33mcg/ml		Injectable solution	7,975,793 L.L
B05XA03	SODIUM CHLORIDE	G	Sodium chloride - 0.9%	0.9%	Injectable solution	3,985,356 L.L
B05XA03	SODIUM CHLORIDE	G	Sodium chloride - 0.9%	0.9%	Injectable solution	5,566,628 L.L
B05XA03	SODIUM CHLORIDE	G	Sodium chloride - 0.9%	0.9%	Injectable solution	519,736 L.L
B05XA03	SODIUM CHLORIDE	G	Sodium chloride - 0.9%	0.9%	Injectable solution	167,780 L.L
B05XA03	SODIUM CHLORIDE	G	Sodium chloride - 0.9%	0.9%	Injectable solution	167,780 L.L
B05XA03	SODIUM CHLORIDE	G	Sodium chloride - 0.9%	0.9%	Injectable solution	166,708 L.L

جبق عرض ونقابة أصحاب المستشفيات مشاكل القطاع وتسلم دعوة إلى ملتقى المستشفيات العربية في القاهرة